PharmaCadence Analytical Services

PharmaCadence is a professional analytical services organization serving the pharmaceutical and life sciences fields with expert LC-MS services. We are known for high quality quantitative LC-MS bioanalytical methods designed to uniquely support each research and early drug development project. We provide a full range of analytical services from early discovery through to clinical research. We specialize in developing and conducting novel biomarker assays as drug development tools. The company founders, Carmen Fernandez-Metzler, Ph.D. and Richard King, Ph.D., are former Merck DMPK scientists with many years of experience discovering and developing new drugs. We pride ourselves on our strong scientific background...

Targeted protein quantification,small molecule bioanalysis,protein and peptide bioanalysis,pk studies,method development,regulated and glp,biomarker assay development,biomarker quantification,tissue bioanalysis,neurosteroids,lipids,prostaglandins,sterols,protein panel assays,assay transfer,method validation,biomarker discovery,and biomarker validation

Pharmacadence analytical services operates in the Research services industry.

Pharmacadence analytical services's revenue is 11m - 100m

Pharmacadence analytical services has 11 - 50 employees.